Corporate / M&A

Financing

Jacobs-Capital-web-640x140

Homburger News

Homburger is advising Jacobs Capital on the sale of Mammut Sports Group

Homburger is acting as lead transaction counsel to Jacobs Capital in connection with its sale of Mammut Sports Group, home of the leading Swiss premium outdoor brand Mammut, to CPE, a Chinese alternative assets manager. The transaction is expected to close within the coming months, subject to customary regulatory approvals and closing conditions.
The Homburger team was co-led by David Oser and Anna Peter (both Corporate / M&amp;A) and included Kaiyan Yeo, Erik Habich and David Fankhauser (all Corporate / M&amp;A), Richard Stäuber and Anna-Katharina Leitz (both Competition), Reto Heuberger, Stefan Oesterhelt and Philippe Weber (all Tax), Stefan Bindschedler (Financing) as well as Gregor Bühler and Joel Fink (both IP / IT).

Employment and Executive Compensation

Competition

Nestle

Homburger advises Nestlé on its partnership with Platinum Equity to create Peranel, a 50:50 joint venture for Nestlé’s waters and premium beverages business

On July 23, 2026, Nestlé (SIX: NESN) and Platinum Equity announced a plan to create Peranel, a 50:50 joint venture for Nestlé’s waters and premium beverages business, designed to establish a dedicated player with strengthened focus to drive growth in a dynamic category.
Spanning more than 30 brands with products sold in 120 countries, Peranel includes iconic natural mineral water brands such as S.Pellegrino, Source Perrier and Acqua Panna as well as premium and functional hydration beverages, the global Nestlé Pure Life brand and other leading local water brands.
The transaction is subject to employee consultation processes and applicable regulatory approvals and is expected to close in H1 2027. It assigns an enterprise value to Peranel of EUR 4.9 bn (CHF 4.5 bn).
Homburger acted as legal counsel to Nestlé on the carve-out in Switzerland and all Swiss law matters in connection with the transaction.
The Homburger team was led by Frank Gerhard and included Magdalena Stock and Constantin Khovrin (all Corporate / M&amp;A), Dieter Grünblatt, Peter Müller, Arbnor Sheholli (all Tax), Richard Stäuber, Anna-Katharina Leitz (both Competition), Roman Richers (Compliance) and Jeremy Reichlin (Employment and Executive Compensation).

Capital Markets

Healthcare / Life Sciences

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

On July 20, 2026, PolyPeptide Group AG (SIX: PPGN), a specialized global Contract Development &amp; Manufacturing Organization (CDMO) for peptide-based active pharmaceutical ingredients, and Samsung Biologics Co., Ltd. announced that they have entered into a transaction agreement under which Samsung Biologics agreed to make an all-cash public tender offer to acquire all publicly held registered shares of PolyPeptide for CHF 44.31 per share. The offer values PolyPeptide’s equity at approximately CHF 1.46 bn. Samsung Biologics published its pre-announcement of the offer today. PolyPeptide’s largest individual shareholder, owning a stake of approximately 55.65% (excluding treasury shares), has committed to tender all of its shares into the offer.
The offer is subject to the satisfaction of customary offer conditions, including a minimum acceptance rate of 66.67% on a fully diluted share count basis and the receipt of regulatory approvals in certain jurisdictions.
Homburger is acting as legal counsel to PolyPeptide Group AG in connection with the transaction. The Homburger team is led by Frank Gerhard and included Micha Fankhauser, Nicola Togni, Patrick Schmidt, Matthias Müller, Pepe Hünerwadel, Matteo Gasser and Filippo Moggi (all Corporate / M&amp;A, Capital Markets), Richard Stäuber, Allegra Arnold and Anna-Katharina Leitz (all Competition), as well as Stefan Oesterhelt (Tax).

Anna-Katharina
Leitz

Homburger is advising Jacobs Capital on the sale of Mammut Sports Group

Homburger advises Nestlé on its partnership with Platinum Equity to create Peranel, a 50:50 joint venture for Nestlé’s waters and premium beverages business

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

Neue Entscheide und Urteile zum Schweizer Wettbewerbsrecht im 3. Quartal 2025

Illuminating the Law and Casting a Tower? The CJEU rules on Art. 22 EUMR in Illumina/Grail

Algorithms and Competition Law – Status and Challenges

Join the Team

Anna-Katharina Leitz

Career

Languages

Bar Registration

Teams

Anna-KatharinaLeitz

Homburger is advising Jacobs Capital on the sale of Mammut Sports Group

Homburger advises Nestlé on its partnership with Platinum Equity to create Peranel, a 50:50 joint venture for Nestlé’s waters and premium beverages business

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

Neue Entscheide und Urteile zum Schweizer Wettbewerbsrecht im 3. Quartal 2025

Illuminating the Law and Casting a Tower? The CJEU rules on Art. 22 EUMR in Illumina/Grail

Algorithms and Competition Law – Status and Challenges

Join the Team

Anna-Katharina Leitz

Career

Languages

Bar Registration

Teams

Anna-Katharina
Leitz